VB4-845 Injection

VB4-845 · Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VB4-845 Injection, covering 2021-04-26 to 2021-04-26. Get the full timeline:

Most recent: Clinical Trial Update: Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer [Phase 3]